April Kam, our Paediatric EM and Critical Care track lead, spent some time with us this week to discuss COVID 19 in the Paediatric population.
April is an Associate Professor in the Department of Pediatrics and the Director of Research and Quality for the division of PEM at McMaster University in Hamilton, Canada.
She has an interest in global health education and has worked around the world.
Check out her extensive CV here.
We are very lucky to have her expertise and energy devoted to DevelopingEM and in March she led a fantastic group of Paeds EM specialists for the 2020 conference in Cartagena, Colombia.
You can check out all the 2020 conference presentations from April and her team (Nate Kupperman from UC Davis, Viviana Pavlicich from Paraguay, Camilo Gutierrez from Kids National in DC, Tanya Solana from Sick Kids Toronto, Laura Galvis from Colombia and Suzanne Beno also from Sick Kids Toronto).
Today April gives us a Canadian and global perspective on how the COVID 19 Pandemic is playing out in Paediatric Emergency Medicine.
In this interview we discuss the prevalence of illness, some of the options for treating the respiratory form of the illness and also describe the evolving knowledge on the inflammatory and vascular forms of the illness in children.
We think you will agree that Paediatric COVID is a fascinating and evolving situation.
Check our all the references April mentioned here.
Children’s Hospital of Eastern Ontario (CHEO) PIMS Guideline.
European Centre for Disease Prevention and Control (ECDC) PIMS Rapid Risk Assessment.
Zhang et al, Science. COVID 19 contact patterns in China.
Ramcharan T et al, Pediatr Cardiol. PIMS UK.
Capone C et al, J Pediatr. MIS-C in New York.
Toubiana J et al, BMJ. KD France.
Feldstein L et al, NEJM. MSIS USA.
We really appreciate April’s time and hope to catch up with her in the next six months to see how the situation continues to evolve.
Stay tuned for more COVID focussed interviews with our global faculty.